Attention-Deficit Hyperactivity Disorder

Resource Center

Research Summaries

Addiction

FDA approves ADHD drug Vyvanse for binge-eating disorder

02/02/2015

The US Food and Drug Administration has approved the stimulant lisdexamfetamine to treat binge-eating disorder, the first product to be approved for the condition.

02/02/2015

Epilepsy

Study: 1 In 5 With Epilepsy May Also Have ADHD

01/19/2015

A new study evaluated the relationship between epilepsy and symptoms of ADHD, as well as how those symptoms affect patients' quality of life.

01/19/2015

Research Summaries

Gestational Diabetes

Weight Gain, Diabetes During Gestation Associated With Increased ADHD Risk in Offspring

09/19/2022

The researchers examined a link between excessive weight gain during pregnancy and gestational diabetes in women and later diagnoses of ADHD in their children.

09/19/2022

Pediatrics

FDA Approves New ADHD Treatment Option for Children

04/07/2021

The US Food and Drug Administration has approved a new nonstimulant drug for the treatment for attention-deficit/hyperactivity disorder in children.

04/07/2021

Pediatrics

ADHD Polypharmacy Rates Are Increasing

07/07/2020

A recent study sought to examine rates of attention-deficit/hyperactivity disorder medication use and psychotherapeutic polypharmacy among US patients aged 2 to 24 years, identify commonly prescribed ADHD...

07/07/2020

Pediatrics

FDA Approves First Video Game-Based Treatment for ADHD

06/17/2020

The US Food and Drug Administration has approved the marketing of the first video game-based digital therapeutic device for the treatment of children aged 8 to 12 years with attention deficit hyperactivity...

06/17/2020

ADHD

New ADHD Guidelines Released

02/04/2020

The Society for Developmental and Behavioral Pediatrics has released a new guideline for the assessment and treatment of children and adolescents with complex attention-deficit/hyperactivity disorder.

02/04/2020

April 2024

Current Issue

April 2024

Volume 64

Issue 4